KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Cash from Investing Activities (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 17 years of Cash from Investing Activities data on record, last reported at -$419.5 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 714.99% year-over-year to -$419.5 million; the TTM value through Dec 2025 reached -$277.8 million, down 107.25%, while the annual FY2025 figure was -$277.8 million, 107.25% down from the prior year.
  • Cash from Investing Activities reached -$419.5 million in Q4 2025 per IONS's latest filing, down from $91.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $212.1 million in Q4 2022 and bottomed at -$419.5 million in Q4 2025.
  • Average Cash from Investing Activities over 5 years is -$34.7 million, with a median of $65.3 million recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: soared 2203.96% in 2023, then tumbled 714.99% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $95.1 million in 2021, then surged by 123.06% to $212.1 million in 2022, then crashed by 112.59% to -$26.7 million in 2023, then surged by 355.36% to $68.2 million in 2024, then crashed by 714.99% to -$419.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$419.5 million in Q4 2025, $91.3 million in Q3 2025, and -$120.1 million in Q2 2025.